Twitxy Saved

Nicolas Tilmans

@ntilmans

On the edge of biochemistry+tech. Waffle enthusiast.

Founder/CEO Anagenex (acquired 2025), VP Engineering Lumiata (acquired 2022), Stanford Biochem PhD 2013
Joined March 2010
1.1K Following 1.2K Followers 927 Posts

Latest posts 5

Nicolas Tilmans @ntilmans
The “don’t diddle your employees” rule is unbeaten.

So much value destruction avoidable by just doing the right thing.

Also “beware people telling you pleasant things that make you more money.”

Sad to see a legend like Jensen go down like this.
Nicolas Tilmans @ntilmans
This is the best description and implementation of how AI will improve drug discovery. I'm helping some companies implement similar processes, @OctantBio and @srikosuri are true pioneers and examples here.
Sri Kosuri Verified account @srikosuri Sep 24
Wrote an essay on how AI has been changing things at Octant, and how we've evolved from thinking about lab-in-the-loop applications to more agentic ways to work on frontier drug programs, where you don't even know what question to answer.
View quoted post on X
1 replies 0 reposts 15 likes 2.3K views View on X
Nicolas Tilmans @ntilmans
One question about the coming Super AI for bio: if frontier models are so good that it's "scary" why can't they distinguish "I'm trying to cure disease" from "I'm doing something bad"?

Surely that's easier than discovering entirely new biology!